Open Access
Subscription Access
An Indispensable Parameters of Ventricular Fibrillation Include Objectives, Etiology, Epidemiology, Pathophysiology, Differential Diagnosis, Treatment, Prognosis, Complications and Healthcare Team Outcomes
Abstract
Ventricular arrhythmias (VA) are defined as arrhythmias that originate from the ventricular myocardium or His-Purkinje system. Ventricular tachycardia (VT), ventricular fibrillation (VF), premature ventricular contractions (PVC), and ventricular flutter are among the subtypes of arrhythmias that fall under this category. All tachyarrhythmias with a QRS complex duration of more than 0.12 seconds can be explained by wide complex tachycardia (WCT). VF is a WCT caused by irregular electrical activity and manifested by a ventricular rate of normally greater than 300 with discrete QRS complexes on the electrocardiogram (ECG). This activity explains the causes, pathophysiology, and presentation of VF and highlights the role of the inter professional team in its management.
References
American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology), Buxton, A. E., Calkins, H., Callans, D. J., DiMarco, J. P., Fisher, J. D., Greene, H. L., Haines, D. E., Hayes, D. L., Heidenreich, P. A., Miller, J. M., Poppas, A., Prystowsky, E. N., Schoenfeld, M. H., Zimetbaum, P. J., Goff, D. C., Grover, F. L., Malenka, D. J., Peterson, E. D., ... Redberg, R. F. (2006). ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures. Circulation, 114(23), 2534–2570. https://doi.org/10.1161/CIRCULATIONAHA.106.180206
Glinge, C., Sattler, S., Jabbari, R., & Tfelt-Hansen, J. (2016). Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction. Journal of Geriatric Cardiology, 13(9), 789–797. https://doi.org/10.11909/j.issn.1671-5411.2016.09.002
Jabbari, R., Engstrøm, T., Glinge, C., Risgaard, B., Jabbari, J., Winkel, B. G., Terkelsen, C. J., Tilsted, H. H., Jensen, L. O., Hougaard, M., Chiuve, S. E., Pedersen, F., Svendsen, J. H., Haunsø, S., Albert, C. M., & Tfelt-Hansen, J. (2015). Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: A nationwide study in Denmark. Journal of the American Heart Association, 4(1), e001399. https://doi.org/10.1161/JAHA.114.001399
Samie, F. H., & Jalife, J. (2001). Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart. Cardiovascular Research, 50(2), 242–250. https://doi.org/10.1016/s0008-6363(01)00243-7
Bezzina, C. R., Pazoki, R., Bardai, A., Marsman, R. F., de Jong, J. S. S. G., Blom, M. T., Scicluna, B. P., Jukema, J. W., Bindraban, N. R., Lichtner, P., Pfeufer, A., Bishopric, N. H., Roden, D. M., Meitinger, T., Chugh, S. S., Myerburg, R. J., Jouven, X., Kääb, S., Dekker, L. R. C., ... Wilde, A. A. M. (2010). Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction. Nature Genetics, 42(8), 688–691. https://doi.org/10.1038/ng.623
Adabag, A. S., Luepker, R. V., Roger, V. L., & Gersh, B. J. (2010). Sudden cardiac death: Epidemiology and risk factors. Nature Reviews Cardiology, 7(4), 216–225. https://doi.org/10.1038/nrcardio.2010.1
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., Gillis, A. M., Granger, C. B., Hammill, S. C., Hlatky, M. A., Joglar, J. A., Kay, G. N., Matlock, D. D., Myerburg, R. J., Page, R. L., ... Heart Rhythm Society. (2018). 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary. Journal of the American College of Cardiology, 72(14), 1677–1749. https://doi.org/10.1016/j.jacc.2017.10.054
Dumas, F., Cariou, A., Manzo-Silberman, S., Grimaldi, D., Vivien, B., Rosencher, J., Empana, J. P., Carli, P., Mira, J. P., Jouven, X., & Spaulding, C. (2010). Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: Insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry. Circulation: Cardiovascular Interventions, 3(3), 200–207. https://doi.org/10.1161/CIRCINTERVENTIONS.109.913665
Honarmand, K., Mepham, C., Ainsworth, C., & Khalid, Z. (2018). Adherence to advanced cardiovascular life support (ACLS) guidelines during in-hospital cardiac arrest is associated with improved outcomes. Resuscitation, 129, 76–81. https://doi.org/10.1016/j.resuscitation.2018.06.027
Chan, P. S., Krumholz, H. M., Nichol, G., Nallamothu, B. K., & American Heart Association National Registry of Cardiopulmonary Resuscitation Investigators. (2008). Delayed time to defibrillation after in-hospital cardiac arrest. New England Journal of Medicine, 358(1), 9–17. https://doi.org/10.1056/NEJMoa0706467
Laina, A., Karlis, G., Liakos, A., Georgiopoulos, G., Oikonomou, D., Kouskouni, E., Chalkias, A., & Xanthos, T. (2016). Amiodarone and cardiac arrest: Systematic review and meta-analysis. International Journal of Cardiology, 221, 780–788. https://doi.org/10.1016/j.ijcard.2016.07.044
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S. E., Clapp-Channing, N., Davidson-Ray, L. D., Fraulo, E. S., Fishbein, D. P., Luceri, R. M., Ip, J. H., & Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. (2005). Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. New England Journal of Medicine, 352(3), 225–237. https://doi.org/10.1056/NEJMoa043399
Refbacks
- There are currently no refbacks.